Combined effect of topical arsenic trioxide and radiation therapy on skin-infiltrating lesions of breast cancer - A pilot study

Anti-Cancer Drugs

Volumn 14, Issue 10, 2003, Pages 825-828

  Lai, Yuen Liang ^a,b,c   Chang, Hen Hong ^d   Huang, Ming Jer ^a   Chang, Kou Hwa ^a   Su, Wen Hao ^a   Chen, Hong Wen ^a   Chung, Chang Hung ^a   Wang, Wen Yu ^a   Lin, Li Hua ^a   Chen, Yu Jen ^a,e  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e CHINESE CULTURE UNIVERSITY   (Taiwan)

Author keywords

Arsenic trioxide; Cutaneous metastasis; Radiotherapy

Indexed keywords

ARSENIC TRIOXIDE;

ACUTE DISEASE; ADULT; AGED; ANOREXIA; ARTICLE; BLOOD SAMPLING; BLOOD TOXICITY; BONE MARROW SUPPRESSION; BREAST CARCINOMA; CANCER INFILTRATION; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG MONITORING; DRUG RESPONSE; ELECTRON BEAM; EVALUATION; FATIGUE; FEMALE; GASTROINTESTINAL TOXICITY; GRANULOCYTOSIS; HUMAN; HYPERPIGMENTATION; INFRARED PHOTOGRAPHY; KIDNEY FUNCTION; LABORATORY TEST; LEUKOPENIA; LINEAR ACCELERATOR; LIVER FUNCTION; LIVER TOXICITY; MALE; MEDICAL ASSESSMENT; NAUSEA; PRIORITY JOURNAL; RADIATION DERMATITIS; RADIOSENSITIVITY; SKIN METASTASIS; THROMBOCYTOPENIA; VISUAL ANALOG SCALE; VOMITING;

EID: 12144291654     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200311000-00008     Document Type: Article

References (12)

1. Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ, et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 1998; 339:1341-1348.
2. Bazarbachi A, Hermine O. Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives. Virus Res 2001; 78:79-92.
3. Shao W, Fanelli M, Ferrara FF, Riccioni R, Rosenauer A, Davison K, et al. Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells. J Natl Cancer Inst 1998; 90:124-133.
4. Siu KP, Chan JY, Fung KP. Effect of arsenic trioxide on human hepatocellular carcinoma HepG2 cells: inhibition of proliferation and induction of apoptosis. Life Sci 2002; 71:275-285.
5. Li X, Ding X, Adrian TE. Arsenic trioxide inhibits proliferation and induces apoptosis in pancreatic cancer cells. Anticancer Res 2002; 22:2205-2213.
6. Jiang XH, Wong BC, Yuen ST, Jiang SH, Cho CH, Lai KC. et al. Arsenic trioxide induces apoptosis in human gastric cancer cells through up-regulation of p53 and activation of caspase-3. Int J Cancer 2001; 91: 173-179.
7. 3). FEBS Lett 2002; 519:195-200.
8. 3 lotion in patients with cutaneous metastatic breast cancer - report of 2 cases. J Intern Med Taiwan 2003; 14:31-36.
9. Bazarbachi A, El Sabban ME, Nasr R, Quignon F, Awaraji C, Kersual J, et al. Arsenic trioxide and interferon-alpha synergize to induce cell cycle arrest and apoptosis in human T-cell lymphotropic virus type I-transformed cells. Blood 1999; 93:278-283.
10. Chakravarthy A, Nicholson B, Kelley M, Beauchamp D, Johnson D, Frexes-steed M, et al. A pilot study of neoadjuvant paclitaxel and radiation with correlative molecular studies in stage II/III breast cancer, Clin Breast Cancer 2000; 1:68-71.
11. Lew YS, Kolozsvary A, Brown SL, Kim JH. Synergistic interaction with arsenic trioxide and fractionated radiation in locally advanced murine tumor. Cancer Res 2002; 62:4202-4205.
12. Rust DM, Soignet SL. Risk/benefit profile of arsenic trioxide. Oncologist 2001; 6(suppl):32-37.